| Literature DB >> 25080588 |
Yvonne S Eisele1, Sarah K Fritschi2, Tsuyoshi Hamaguchi3, Ulrike Obermüller4, Petra Füger4, Angelos Skodras4, Claudia Schäfer4, Jörg Odenthal4, Mathias Heikenwalder5, Matthias Staufenbiel4, Mathias Jucker1.
Abstract
Deposition of aggregated amyloid-β (Aβ) peptide in brain is an early event and hallmark pathology of Alzheimer's disease and cerebral Aβ angiopathy. Experimental evidence supports the concept that Aβ multimers can act as seeds and structurally corrupt other Aβ peptides by a self-propagating mechanism. Here we compare the induction of cerebral β-amyloidosis by intraperitoneal applications of Aβ-containing brain extracts in three Aβ-precursor protein (APP) transgenic mouse lines that differ in levels of transgene expression in brain and periphery (APP23 mice, APP23 mice lacking murine APP, and R1.40 mice). Results revealed that beta-amyloidosis induction, which could be blocked with an anti-Aβ antibody, was dependent on the amount of inoculated brain extract and on the level of APP/Aβ expression in the brain but not in the periphery. The induced Aβ deposits in brain occurred in a characteristic pattern consistent with the entry of Aβ seeds at multiple brain locations. Intraperitoneally injected Aβ could be detected in blood monocytes and some peripheral tissues (liver, spleen) up to 30 d after the injection but escaped histological and biochemical detection thereafter. These results suggest that intraperitoneally inoculated Aβ seeds are transported from the periphery to the brain in which corruptive templating of host Aβ occurs at multiple sites, most efficiently in regions with high availability of soluble Aβ.Entities:
Keywords: Abeta; cerebral beta-amyloidosis; peripheral induction; seeding
Mesh:
Substances:
Year: 2014 PMID: 25080588 PMCID: PMC6608275 DOI: 10.1523/JNEUROSCI.1608-14.2014
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167